About Sernova
Sernova is a company based in London (Canada) founded in 1998. The company has 17 employees as of October 31, 2024. Sernova offers products and services including Cell Pouch™. Sernova operates in a competitive market with competitors including NGM Biopharmaceuticals, MannKind Corp, Rhythm Pharmaceuticals, Corcept and ViaCyte, among others.
- Headquarter London, Canada
- Employees 17 as on 31 Oct, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sernova Biotherapeutics Inc
-
Annual Revenue
Not available
-
Net Profit
-$11.22 M (USD)51.1as on Oct 31, 2025
-
EBITDA
-$10.54 M (USD)52.77as on Oct 31, 2025
-
Latest Funding Round
$344.51 K (USD), Post-IPO
Oct 31, 2025
-
Investors
National Research Council Canada
& 1 more
-
Employee Count
17
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sernova
Sernova is a publicly listed company on the TSX with ticker symbol SVA in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sernova
Sernova offers a comprehensive portfolio of products and services, including Cell Pouch™.
Device that restores bodily functions for chronic disease patients.
People of Sernova
Unlock access to complete
Unlock access to complete
Funding Insights of Sernova
Investors in Sernova
Sernova has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include National Research Council Canada and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Scientific and technological research is conducted for Canada's benefit.
|
Locked | Locked | Locked |
Investor details for Sernova
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sernova
Investment portfolio details for Sernova
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sernova
Detailed financials for Sernova
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sernova Comparisons
Peer comparison for Sernova
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sernova
Sernova operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NGM Biopharmaceuticals, MannKind Corp, Rhythm Pharmaceuticals, Corcept and ViaCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| Locked | Locked | Locked |
Developer of small-molecule drugs
|
|
| Locked | Locked | Locked |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| Locked | Locked | Locked |
Developer of cortisol modulators for the treatment of various diseases
|
|
| Locked | Locked | Locked |
Cell therapy for diabetes is developed from stem cells.
|
|
| Locked | Locked | Locked |
Developer of therapies for treating nonalcoholic steatohepatitis and other liver and metabolic disorders
|
Detailed competitors of Sernova
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sernova
Complete news archive for Sernova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sernova
Sernova was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Sernova is headquartered in London, Canada. It is registered at London, Ontario, Canada.
As of Oct 31, 2024, the latest employee count at Sernova is 17.
Sernova Corp. was founded in 1998 in London, Canada, as a regenerative medicine company. Therapeutic cells are transplanted using the Cell Pouch, an implantable device designed for long-term release of proteins and hormones to address conditions like diabetes, hemophilia, and thyroid disease. Sertolin, a cell-based immune protection technology, is being developed to minimize anti-rejection drug needs. Clinical efforts are primarily directed toward insulin-dependent diabetes treatment.
Sernova's top competitors include Rhythm Pharmaceuticals, MannKind Corp and Corcept.
Sernova offers Cell Pouch™.
Yes, Sernova is publicly traded on TSX under the ticker symbol SVA.
Sernova has 2 investors. Key investors include National Research Council Canada, and European Union.
The ticker symbol of Sernova is SVA on TSX.